EP2488874A4 - Biomarqueur d'identification de cellules tumorales de mélanome - Google Patents

Biomarqueur d'identification de cellules tumorales de mélanome

Info

Publication number
EP2488874A4
EP2488874A4 EP10824012.8A EP10824012A EP2488874A4 EP 2488874 A4 EP2488874 A4 EP 2488874A4 EP 10824012 A EP10824012 A EP 10824012A EP 2488874 A4 EP2488874 A4 EP 2488874A4
Authority
EP
European Patent Office
Prior art keywords
biomarker
melanoma
identification
tumor cells
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10824012.8A
Other languages
German (de)
English (en)
Other versions
EP2488874A2 (fr
Inventor
Rhoda M Alani
Whei F Moriarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of EP2488874A2 publication Critical patent/EP2488874A2/fr
Publication of EP2488874A4 publication Critical patent/EP2488874A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP10824012.8A 2009-10-13 2010-10-13 Biomarqueur d'identification de cellules tumorales de mélanome Withdrawn EP2488874A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25112309P 2009-10-13 2009-10-13
US25707409P 2009-11-02 2009-11-02
PCT/US2010/052486 WO2011047033A2 (fr) 2009-10-13 2010-10-13 Biomarqueur d'identification de cellules tumorales de mélanome

Publications (2)

Publication Number Publication Date
EP2488874A2 EP2488874A2 (fr) 2012-08-22
EP2488874A4 true EP2488874A4 (fr) 2013-08-14

Family

ID=43876845

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10824012.8A Withdrawn EP2488874A4 (fr) 2009-10-13 2010-10-13 Biomarqueur d'identification de cellules tumorales de mélanome

Country Status (7)

Country Link
US (1) US20110091384A1 (fr)
EP (1) EP2488874A4 (fr)
JP (1) JP2013507641A (fr)
CN (1) CN102667484A (fr)
AU (1) AU2010306899B2 (fr)
CA (1) CA2777235A1 (fr)
WO (1) WO2011047033A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116362A2 (fr) 2005-04-25 2006-11-02 The Trustees Of Boston University Substrats structures pour le profilage optique de surface
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
US9036888B2 (en) 2012-04-30 2015-05-19 General Electric Company Systems and methods for performing quality review scoring of biomarkers and image analysis methods for biological tissue
US8737709B2 (en) 2012-04-30 2014-05-27 General Electric Company Systems and methods for performing correlation analysis on clinical outcome and characteristics of biological tissue
US20150005184A1 (en) * 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
WO2015095686A1 (fr) 2013-12-20 2015-06-25 Trustees Of Boston University Analyses et méthodes associées au traitement de mélanomes
US20160024595A1 (en) * 2014-07-22 2016-01-28 Dermtech International Characterization of melanoma using a molecular signature
WO2016118092A1 (fr) * 2015-01-19 2016-07-28 Onur Mehmet Ali Nanoparticules d'or fonctionnalisées avec sémaphorine 3f et leur préparation
AU2016327573B2 (en) 2015-09-22 2022-07-14 Trustees Of Boston University Multiplexed phenotyping of nanovesicles
WO2017136676A1 (fr) 2016-02-05 2017-08-10 Nanoview Diagnostics Inc. Détection d'exosomes ayant des marqueurs de surface
GB201602305D0 (en) * 2016-02-09 2016-03-23 Medical Res Council And Imp Innovations Ltd TB Biomarkers
BR112019024481A2 (pt) * 2017-05-25 2020-07-14 Liquid Biopsy Research LLC métodos para detecção de melanoma
WO2019130503A1 (fr) * 2017-12-27 2019-07-04 コニカミノルタ株式会社 Procédé d'acquisition d'informations
CA3090785A1 (fr) 2018-02-14 2019-08-22 John Daniel Dobak Iii Nouveaux classificateurs de genes et leurs utilisations dans des cancers de la peau sans melanome
AU2019247511B2 (en) * 2018-04-06 2025-10-16 Atyr Pharma, Inc. Compositions and methods comprising anti-NRP2 antibodies
CN112805563B (zh) * 2018-05-18 2025-06-13 约翰·霍普金斯大学 用于评估和/或治疗癌症的无细胞dna
WO2019232321A1 (fr) 2018-06-01 2019-12-05 NanoView Biosciences, Inc. Compositions, systèmes et procédés de détection améliorée sans marqueur et à base de fluorescence de nanoparticules
JP2022524641A (ja) 2019-03-26 2022-05-09 ダームテック，インク． 皮膚癌における新規な遺伝子分類子とその使用
CA3156803A1 (fr) 2019-10-03 2021-04-08 Atyr Pharma, Inc. Compositions et methodes comprenant des anticorps anti-nrp2
JP2023524750A (ja) * 2020-05-04 2023-06-13 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ メラノーマの検出

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008141275A1 (fr) * 2007-05-11 2008-11-20 The Johns Hopkins University Biomarqueurs pour mélanomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1037981A1 (fr) * 1997-12-09 2000-09-27 Children's Medical Center Corporation Inhibiteurs solubles du facteur de croissance de l'endothelium vasculaire et leurs utilisations
EP2272947B1 (fr) * 2000-09-05 2016-08-10 Biosight Ltd Promedicaments peptidiques anticancereux conjugues
JP5745840B2 (ja) * 2007-05-17 2015-07-08 ジェネンテック， インコーポレイテッド 抗ニューロピリン２抗体による腫瘍転移の阻害
US20110286916A1 (en) * 2008-11-20 2011-11-24 Jose Miguel Aste-Amezaga Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008141275A1 (fr) * 2007-05-11 2008-11-20 The Johns Hopkins University Biomarqueurs pour mélanomes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIELENBERG D R ET AL: "Neuropilins in neoplasms: Expression, regulation, and function", EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS, US, vol. 312, no. 5, 10 March 2006 (2006-03-10), pages 584 - 593, XP024944926, ISSN: 0014-4827, [retrieved on 20060310], DOI: 10.1016/J.YEXCR.2005.11.024 *
ERICA C. RUSHING ET AL: "Neuropilin-2: a novel biomarker for malignant melanoma?", HUMAN PATHOLOGY, vol. 43, no. 3, 1 March 2012 (2012-03-01), pages 381 - 389, XP055069392, ISSN: 0046-8177, DOI: 10.1016/j.humpath.2011.05.008 *
MEDIC SANDRA ET AL: "Molecular markers of circulating melanoma cells", PIGMENT CELL RESEARCH, MUNKSGAARD INTERNATIONAL PUBLISHERS, CAMBRIDGE, MA, DK, vol. 20, no. 2, 1 April 2007 (2007-04-01), pages 80 - 91, XP009140695, ISSN: 0893-5785, [retrieved on 20061220], DOI: 10.1111/J.1600-0749.2006.00356.X *
See also references of WO2011047033A2 *
SUSANNA L. COOKE ET AL: "Processed pseudogenes acquired somatically during cancer development", NATURE COMMUNICATIONS, vol. 5, 1 April 2014 (2014-04-01), XP055160124, ISSN: 2041-1723, DOI: 10.1038/ncomms4644 *

Also Published As

Publication number Publication date
US20110091384A1 (en) 2011-04-21
AU2010306899B2 (en) 2015-07-23
WO2011047033A9 (fr) 2011-12-01
CN102667484A (zh) 2012-09-12
JP2013507641A (ja) 2013-03-04
CA2777235A1 (fr) 2011-04-21
AU2010306899A1 (en) 2012-05-03
WO2011047033A3 (fr) 2011-08-04
EP2488874A2 (fr) 2012-08-22
WO2011047033A2 (fr) 2011-04-21

Similar Documents

Publication Publication Date Title
EP2488874A4 (fr) Biomarqueur d'identification de cellules tumorales de mélanome
IL289062A (en) Molecular profiling of tumors
PL2438445T3 (pl) Sposoby diagnozowania raków gruczołu krokowego
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
EP2488630A4 (fr) Induction de cellules pluripotentes
EP2580352A4 (fr) Caractérisation de voies de cellules
EP2412825A4 (fr) Marqueurs de cellules souches leucémiques
IL226477A (en) Salts and polymorphic forms of Aptinib
EP2456858A4 (fr) Différenciation de cellules souches embryonnaires humaines
EP2335075A4 (fr) Méthodes de détection de cellules tumorales circulantes
EP2480576A4 (fr) Antagonistes de pcsk9
EP2472765C0 (fr) Améliorations de la capacité d'écoute pour signaux de référence
BR112012001480A2 (pt) Diferenciação de células-tronco embriônicas humanas
EP2452515A4 (fr) Initialisation de femtocellules
EP2414510A4 (fr) Cellules souches pluripotentes induites
EP2437790A4 (fr) Procédés de conjugaison
SG10201401643PA (en) Methods for assessing cytotoxicity of single cells
EP2227812A4 (fr) Détection de cellules mémoire
PT2498610T (pt) Moduladores seletivos de recetor de esfingosina 1 fosfato e métodos de síntese quiral
AP3389A (en) Measurement reporting of neighbor cells
EP2456440A4 (fr) Inhibiteurs de quinoléinone pde2
BRPI1008744A2 (pt) hidrotratamento de caboidratos
EP2516615A4 (fr) Bioréacteurs améliorés
IL215645A0 (en) Inhibitors of cognitive decline
IL217833A0 (en) Inhibitors of cognitive decline

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120514

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1174973

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20130717

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/532 20060101ALI20130711BHEP

Ipc: G01N 33/574 20060101AFI20130711BHEP

Ipc: G01N 33/68 20060101ALI20130711BHEP

17Q First examination report despatched

Effective date: 20140508

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161115